[{"orgOrder":0,"company":"Takeda Pharmaceutical","sponsor":"Johnson & Johnson","pharmaFlowCategory":"D","therapeuticArea":"Hematology","country":"JAPAN","productType":"Large molecule","year":"2020","type":"Termination","leadProduct":"Human fibrinogen","moa":"","graph1":"Hematology","graph2":"Approved","graph3":"Takeda Pharmaceutical","amount2":0.40000000000000002,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Hematology","amount2New":0.40000000000000002,"dosageForm":"Patch","sponsorNew":"Takeda Pharmaceutical \/ Johnson & Johnson","highestDevelopmentStatusID":"12","companyTruncated":"Takeda Pharmaceutical \/ Johnson & Johnson"},{"orgOrder":0,"company":"Takeda Pharmaceutical","sponsor":"Corza","pharmaFlowCategory":"D","therapeuticArea":"Hematology","country":"JAPAN","productType":"Large molecule","year":"2020","type":"Divestment","leadProduct":"Human Fibrinogen","moa":"","graph1":"Hematology","graph2":"Approved","graph3":"Takeda Pharmaceutical","amount2":0.42999999999999999,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Hematology","amount2New":0.42999999999999999,"dosageForm":"Patch","sponsorNew":"Takeda Pharmaceutical \/ Corza","highestDevelopmentStatusID":"12","companyTruncated":"Takeda Pharmaceutical \/ Corza"}]

Find Clinical Drug Pipeline Developments & Deals for Thrombin

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
filter

Year

filter

DEALS // DEV.

filter

Country

filter
Sponsor
filter

Therapeutic Area

filter

Study Phase

filter

Deal Type

filter

Product Type

filter

Dosage Form

filter

Lead Product

filter

Target

Therapeutic Area by Lead Product

ForexGraph

Study Phase by Lead Product

ForexGraph

Company by Lead Product

ForexGraph

Top Deals by Deal Size (USD bn)

ForexGraph

01

Pharma, Lab & Chemical Expo
Not Confirmed
Pharma, Lab & Chemical Expo
Not Confirmed

Details : Under the terms of the agreement, upon close, Corza Health will acquire the assets and licenses that support the development and commercialization of TachoSil®, while Takeda will maintain ownership of the manufacturing facility in Linz, Austria.

Brand Name : TachoSil

Molecule Type : Large molecule

Upfront Cash : 427.0 million

September 16, 2020

Lead Product(s) : Human Fibrinogen,Thrombin

Therapeutic Area : Hematology

Highest Development Status : Approved

Sponsor : Corza

Deal Size : $427.0 million

Deal Type : Divestment

blank

02

Pharma, Lab & Chemical Expo
Not Confirmed
Pharma, Lab & Chemical Expo
Not Confirmed

Details : In late March, EU antitrust regulators had expressed concern about the deal and opened a full investigation into it.

Brand Name : Undisclosed

Molecule Type : Large molecule

Upfront Cash : Undisclosed

April 10, 2020

Lead Product(s) : Human fibrinogen,Thrombin

Therapeutic Area : Hematology

Highest Development Status : Approved

Sponsor : Johnson & Johnson

Deal Size : $400.0 million

Deal Type : Termination

blank